Medical Scientist Training Program, Medical University of South Carolina, Charleston, South Carolina, USA.
Department of Neurosurgery, Medical University of South Carolina, Charleston, South Carolina, USA.
J Neurointerv Surg. 2019 Aug;11(8):847-851. doi: 10.1136/neurintsurg-2018-014381. Epub 2019 Feb 2.
Endovascular thrombectomy (ET) is the standard of care for treatment of acute ischemic stroke (AIS) secondary to large vessel occlusion. The elderly population has been under-represented in clinical trials on ET, and recent studies have reported higher morbidity and mortality in elderly patients than in their younger counterparts.
To use machine learning algorithms to develop a clinical decision support tool that can be used to select elderly patients for ET.
We used a retrospectively identified cohort of 110 patients undergoing ET for AIS at our institution to train a regression tree model that can predict 90-day modified Rankin Scale (mRS) scores. The identified algorithm, termed SPOT, was compared with other decision trees and regression models, and then validated using a prospective cohort of 36 patients.
When predicting rates of functional independence at 90 days, SPOT showed a sensitivity of 89.36% and a specificity of 89.66% with an area under the receiver operating characteristic curve of 0.952. Performance of SPOT was significantly better than results obtained using National Institutes of Health Stroke Scale score, Alberta Stroke Program Early CT score, or patients' baseline deficits. The negative predictive value for SPOT was >95%, and in patients who were SPOT-negative, we observed higher rates of symptomatic intracerebral hemorrhage after thrombectomy. With mRS scores prediction, the mean absolute error for SPOT was 0.82.
SPOT is designed to aid clinical decision of whether to undergo ET in elderly patients. Our data show that SPOT is a useful tool to determine which patients to exclude from ET, and has been implemented in an online calculator for public use.
血管内血栓切除术(ET)是治疗大动脉闭塞引起的急性缺血性脑卒中(AIS)的标准治疗方法。临床试验中老年人的代表性不足,最近的研究报告称,老年患者的发病率和死亡率高于年轻患者。
使用机器学习算法开发一种临床决策支持工具,用于选择接受 ET 的老年患者。
我们使用机构内接受 ET 治疗的 110 名 AIS 患者的回顾性队列来训练回归树模型,该模型可以预测 90 天改良 Rankin 量表(mRS)评分。该算法命名为 SPOT,与其他决策树和回归模型进行了比较,然后使用 36 名患者的前瞻性队列进行了验证。
在预测 90 天功能独立性率时,SPOT 的敏感性为 89.36%,特异性为 89.66%,接受者操作特征曲线下面积为 0.952。SPOT 的性能明显优于国立卫生研究院脑卒中量表评分、阿尔伯塔卒中计划早期 CT 评分或患者基线缺陷的结果。SPOT 的阴性预测值>95%,在 SPOT 阴性的患者中,我们观察到血栓切除术后症状性颅内出血的发生率较高。在 mRS 评分预测方面,SPOT 的平均绝对误差为 0.82。
SPOT 旨在帮助临床决策是否对老年患者进行 ET。我们的数据表明,SPOT 是一种有用的工具,可以确定哪些患者不应接受 ET,并已在在线计算器中实施,供公众使用。